Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-31971318
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
Canada